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Folate Receptor- Is a Cofactor
for Cellular Entry by Marburg
and Ebola Viruses
exist. First, due to pretranslational processing of EBO
GP but not MBG GP, an additional EBO GP product,
sGP, is produced along with the longer membrane-
bound form (Volchkov et al., 1995; Sanchez et al., 1996).
Second, membrane-bound GP expressed by EBO, but
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mediate entry of filoviruses. Previously, it was proposed
that the asialoglycoprotein receptor (ASGP-R) may facil-
itate MBG infection of liver cells (Becker et al., 1995).Summary
However, since both MBG and EBO viruses infect an
extensive range of mammalian cell types (Yang et al.,Human infections by Marburg (MBG) and Ebola (EBO)
viruses result in lethal hemorrhagic fever. To identify 1998; Wool-Lewis and Bates, 1998; Chan et al., 2000b)
that do not express ASGP-R, other relevant cellular fac-cellular entry factors employed by MBG virus, nonin-
fectible cells transduced with an expression library tors must exist that likely are widely expressed and
highly conserved.were challenged with a selectable pseudotype virus
packaged by MBG glycoproteins (GP). A cDNA encod- Previous studies using pseudotype viruses packaged
by MBG or EBO GP demonstrated that T cells are non-ing the folate receptor- (FR-) was recovered from
cells exhibiting reconstitution of viral entry. A FR- permissive for entry (Wool-Lewis and Bates, 1998; Yang
et al., 1998; Chan et al., 2000b). We utilized this informa-cDNA was recovered in a similar strategy employing
EBO pseudotypes. FR- expression in Jurkat cells fa- tion to design a genetic complementation protocol to
identify cellular factors mediating entry by MBG or EBOcilitated MBG or EBO entry, and FR-blocking reagents
inhibited infection by MBG or EBO. Finally, FR- bound viruses. From functionally reconstituted cells permissive
for infection by MBG and the Zaire subtype of EBOcells expressing MBG or EBO GP and mediated syncy-
tia formation triggered by MBG GP. Thus, FR- is a (EBO-Z), we identified the folate receptor- (FR-) as a
mediator of entry utilized by both viruses. This identifica-significant cofactor for cellular entry for MBG and EBO
viruses. tion offers direct evidence that MBG and EBO viruses
share a common pathway for infection and may provide
a basis for developing new antiviral strategies directedIntroduction
against these lethal pathogens.
Marburg (MBG) and Ebola (EBO) filoviruses cause fatal
hemorrhagic fevers characterized by widespread tissue Results
infection and destruction (Peters et al., 1996). They are
filamentous RNA viruses, packaged by lipid membrane Genetic Reconstitution of Entry into Target Cells
envelopes. Despite primary sequence variation, all filovi- by MBG Virus
ruses have substantial similarity in genomic and virion To develop a quantitative, single-cycle infection system
structure (Peters et al., 1996) and infect an extensive for studying MBG virus entry, MBG GP was incorporated
and comparable range of mammalian cell types and into pseudotype viruses carrying an HIV-1 genome lack-
species (Yang et al., 1998; Wool-Lewis and Bates, 1998; ing env but containing a luciferase reporter gene (pNL-
Chan et al., 2000b). Luc-ER) as previously described (Chan et al., 2000b).
Filovirus entry into target cells is mediated by the The vesicular stomatitis virus-G (VSV) GP was packaged
binding of transmembrane virus envelope glycoproteins into similar pseudovirions. Challenge of human HeLa
(GP) to an unknown cell surface factor(s) (Peters et al., cells with either pseudotype resulted in significant virus
1996). Both MBG GP (Volchkov et al., 2000) and EBO entry (Figure 1A). In contrast, while permissive for VSV
GP (Volchkov et al., 1998) are expressed as precursor entry, human Jurkat T cells were not susceptible to MBG
polyproteins that are cleaved intracellularly into an ex- entry. Therefore, HeLa cells, but not Jurkat cells, express
tracellular protein (GP1) and a membrane-anchored pro- significant levels of a relevant cellular factor(s) that con-
tein (GP2). GP1 presumably initiates infection by binding trols entry mediated by MBG GP.
the target cell surface. While MBG and EBO viruses To construct a system of genetic complementation
have common features in GP structure, tropism, and (Figure 1B), a retroviral cDNA library (pLIB-HeLa) derived
pathogenesis, significant differences among them also from HeLa was incorporated into pseudotype virions. As
target cells for this study, we used a highly transducible
derivative of Jurkat cells, Jurkat-EctR, which stably ex-4 Correspondence: mgoldsmith@gladstone.ucsf.edu
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Figure 1. A Genetic Complementation Strat-
egy Based on Jurkat Cells and a Retroviral
Expression Library
(A) HeLa cells, but not Jurkat cells, are per-
missive for entry mediated by MBG GP. Pseu-
dotype virus infection was quantitated by
measuring luciferase activity. Data represent
the means derived from three separate infec-
tions ( SEM).
(B) Selection strategy to recover cDNA inserts
encoding cellular factors that reconstitute
permissivity for MBG virus entry in Jurkat
cells expressing the ecotropic murine leuke-
mia virus receptor (EctR).
press the ecotropic murine leukemia virus (MLV) recep- permeability that might nonspecifically increase entry
of diverse viruses.tor yet are nonpermissive for entry by MBG pseudotypes
(data not shown). Jurkat-EctR cells were transduced
with the retroviral library or with pseudovirions carrying Folate Receptor- Reconstitutes Permissivity
for MBG Pseudotype Entrya GFP reporter gene (pLIB-GFP) to allow for monitoring
of transduction efficiency (30%–40%). Library-trans- To identify the relevant library cDNA insert, PCR amplifi-
cation of DNA from reconstituted cells (bulk culture 2-23)duced cells were then challenged with a selectable MBG
pseudotype virus (MBG-blasti) in which MBG GP was was performed using primers based on sequences flank-
ing the cDNA inserts. Four inserts were found to containused to package an env-negative HIV-1 provirus (pHIV-
blasti) containing the blasticidin S deaminase gene. Se- small open reading frames (ORF). One carried perfect
identity with the 3 two-thirds of the known cDNA sequencelection in blasticidin S was begun 2 days later. After
selection, cell viability was quantitated by Trypan Blue encoding for the human folate receptor- (FR-), begin-
ning with an in-frame internal methionine codon (Met-exclusion. In cultures of parental Jurkat-EctR cells chal-
lenged with no pseudovirions, library-transduced cells #92) and carrying an intact signal sequence for attach-
ment of the membrane anchor. Flow cytometry verifiedchallenged with no pseudovirions, or parental cells chal-
lenged with MBG-blasti pseudotypes, all cells died expression of FR- on HeLa cells (Figure 2B), on the
F10 subclone derived from reconstituted Jurkat-EctRwithin 8 days, and no viable cells were recovered over
a 3-week interval. In contrast, in the library-transduced culture 2-23 (Figure 2C), and on other permissive cell
types such as Vero E6 (Figure 2D), typically used to pas-samples challenged with MBG-blasti, viable cells were
readily detected after 8 days of selection and were ex- sage filoviruses in cell culture (Peters et al., 1996). North-
ern blot analysis confirmed FR expression in these aspanded.
well as additional permissive cell types such as human
(HOS) and dog osteosarcoma cells (data not shown).Verification of Permissivity for MBG Virus Entry
in Selected Jurkat-EctR Cells To seek independent confirmation that FR- reconsti-
tutes permissivity, equivalent numbers of Jurkat-EctRTo confirm that these viable cells were permissive for
MBG virus entry, they were rechallenged with MBG lucif- cells expressing either FR- or GFP were challenged
with blasti pseudotypes, selected in blasticidin S, anderase virus. Unlike untransduced parental Jurkat-EctR
cells that yielded negligible luciferase signals, all blastic- monitored for viability. Cells expressing either GFP or
FR- were equally permissive for entry by VSV-blastiidin-selected bulk cultures (such as 2-11, 2-14, 2-23,
2-24) allowed for significant MBG infection (Figure 2A). pseudotypes, as demonstrated by comparable growth
of viable cells after 3 days of selection (Figure 3A). AImportantly, these recovered cells remained nonpermis-
sive for entry by a negative control pseudotype pack- small but detectable number of cells was periodically
amplified under selection in the FR--negative controlaged by the HIV-1 JR-FL envelope GP (data not shown).
Therefore, MBG entry was not facilitated by a factor sample after challenge with MBG-blasti pseudotypes,
perhaps due to the high sensitivity of the viral entryspecific for HIV components expressed in the pseu-
dotype viruses, nor was it the result of increases in assay. Nonetheless, after 15 days of selection, the cul-
ture expressing FR- exhibited a more than 8-fold greaterendocytic activity or general alterations in cell surface
Folate Receptor- Mediates Filovirus Entry
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Figure 2. Reconstitution of Permissivity for
MBG Entry by Library Transduction Corre-
lates with FR- Expression
(A) Library-transduced Jurkat-EctR cells chal-
lenged with MBG-blasti virus and selected for
survival (bulk cultures 2-11, 2-14, 2-23, and
2-23) are permissive for entry by MBG lucifer-
ase virus. Displayed values represent the
means derived from three separate infections
( SEM).
(B) Flow cytometry confirms that HeLa cells
express FR-. Cells were stained with mono-
clonal antibody raised against soluble bovine
FR- (filled curve) or isotype control (outlined
curve).
(C) Anti-bovine FR- staining reveals FR-
expression on Jurkat-EctR F10 cells (filled
curve), but not parental cells (outlined curve).
(D) Vero E6 cells express FR-. To detect epi-
topes on simian FR-, cells were stained with
anti-human FR- (filled curve) or isotype con-
trol (outlined curve).
amplification of viable cells after challenge with MBG- To determine if more specific FR-blocking reagents
could inhibit MBG entry, Jurkat-EctR F10 cells wereblasti virus compared to the low levels of background
permissivity in cells expressing GFP. In contrast, inde- treated with a monoclonal anti-human FR- antibody
(Franklin et al., 1994). MBG infection was specificallypendent expression of other recovered library inserts
encoding a start codon and an ORF did not allow for resto- and potently reduced by anti-FR- (Figure 4C). Similarly,
the natural ligand of FR-, folic acid, was tested asration of permissivity (data not shown). Therefore, these
results provide direct genetic evidence that FR- can a specific inhibitor of MBG entry. Naturally permissive
human osteosarcoma (HOS) cells were preincubatedserve as a specific mediator for infection by MBG virus.
To verify reconstitution of infectibility for wild-type in folic acid-containing media followed by pseudotype
virus challenge. HOS cells were chosen as target cellsMBG virus in FR--positive cells, F10 cells were chal-
lenged with wild-type MBG virus, stained with anti-MBG since they are more highly permissive for pseudotype
filovirus entry than F10, HeLa, or Vero E6 cells (Chan etantisera, and visualized by immunofluorescence. Al-
though high levels of reconstitution were not observed, al., 2000b) and thus could be challenged with smaller
viral inocula. While VSV entry was minimally inhibited,positive staining was nonetheless detected in F10 cells,
but not parental cells, after MBG inoculation (Figures MBG entry was significantly reduced in a dose-depen-
dent manner (Figure 4D). Additionally, a cleaved, soluble3B and 3C). Taken together with the fact that FR- can
directly reconstitute MBG pseudotype entry, these data form of bovine FR- (folate binding protein, FBP) was
used to compete for the binding of MBG GP expressedindicate that expression of FR- successfully comple-
mented a key step in cellular entry important for both on the virion envelope. Luciferase viruses were preincu-
bated with FBP. HOS cells were then inoculated withpseudotype and wild-type MBG viruses.
these mixtures, and infection level was compared with
that of uncomplexed virus. MBG entry was specificallyFR--Specific Antagonists Inhibit MBG Entry
FR- is a glycosyl-phosphatidylinositol-linked (GPI- inhibited by more than 50% by FBP (Figure 4E). There-
fore, specific inhibition by anti-FR-, folic acid, and solu-linked) protein that binds folic acid for transport into
the cytoplasm (Antony, 1996). GPI-linked proteins are ble FBP indicates not only that FR- facilitates MBG
virus entry in both genetically reconstituted cells andsensitive to cleavage by phospholipase C (PLC). Be-
cause HeLa cells tolerate the cytotoxic effects of PLC naturally permissive cells, but also that this function
likely relies on it directly binding MBG virions.well (data not shown), these cells were pretreated with
PLC followed by challenge with pseudotype luciferase
viruses. MBG pseudotype infection decreased markedly FR- Mediates Membrane Fusion
Triggered by MBG GPand in a dose-dependent manner under these condi-
tions, unlike amphotropic (Ampho) MLV pseudotype vi- The role of FR- in cell-cell fusion driven by MBG GP
was also assessed. 293T cells overexpressing MBG GPrus (Figure 4A). A specific, dose-dependent effect on
MBG entry was also seen upon treatment of F10 cells were cocultivated with cells overexpressing either CD4
or FR-. Because fusion mediated by MBG GP may be(Figure 4B) at noncytotoxic doses confirmed to cleave
FR- from the surface of FR--positive Jurkat cells (data pH-dependent (Chan et al., 2000b), syncytia formation
(3 nuclei) was quantitated after pulsing cells at pH 5 ornot shown). Specific inhibition in two different target cell
types provides further support for a role for a GPI-linked pH 7 and allowing for recovery. As described previously
(Vey et al., 1992), expression of the influenza hemagluti-protein such as FR- in MBG entry.
Cell
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Figure 4. Inhibition of MBG Pseudotype Entry with FR-Specific
Figure 3. FR- Reconstitutes Permissivity for MBG Entry in Jurkat- Blocking Reagents
EctR Cells Pretreatment of (A) HeLa cells or (B) F10 cells with phospholipase
(A) Jurkat-EctR cells expressing FR- are permissive for entry by C (PLC) specifically abrogates MBG pseudotype entry in a dose-
MBG-blasti virus. GFP- or FR--positive cells were inoculated with dependent manner. (C) Entry by MBG luciferase virus into F10 cells
blasti viruses, selected in blasticidin S, and monitored for cell viabil- is specifically abrogated by anti-human FR- IgG1 compared with
ity. Displayed values are representative of two separate reconstitu- that seen with isotype control (anti-HIV p24 IgG1). (D) Dose-depen-
tion procedures. dent inhibition of MBG pseudotype entry into human osteosarcoma
(B) FR--positive F10 cells are infectible (white arrow) by wild-type (HOS) cells by folic acid. (E) MBG pseudotype infection of HOS
MBG virus. F10 cells were challenged with MBG virus and stained cells specifically decreases in the presence of soluble bovine FBP.
using anti-MBG antisera for indirect immunofluorescence analysis Displayed values in (A)–(E) are the means derived from three sepa-
(IFA). rate infections ( SEM).
(C) F10 cells, but not parental cells, are infectible by wild-type MBG
virus. Vero E6, Jurkat-EctR parental, and F10 cells were challenged
with wild-type MBG virus at increasing multiplicity of infection (MOI),
EBO-Z entry (Yang et al., 1998; Chan et al., 2000b).and infected cells were quantitated by IFA.
Therefore, after HeLa library delivery, transduced Jur-
kat-EctR cells were challenged with a pseudotype virus
packaged by EBO-Z GP (EBO-Z-blasti) and selected innin protein (HA) allowed for robust formation of syncytia
(100 per well) when exposed to pH 5 but not pH 7 blasticidin S. Only library-transduced, but not parental,
cultures that had been challenged by EBO-Z-blasti virus(Figure 5A). No significant fusion was detected at either
pH in cultures expressing MBG GP with CD4 (Figure yielded viable cells after selection. Individual cell clones
surviving selection, such as A7-1, were indeed infectible5B), MBG GP alone, FR- alone, or ecotropic MLV GP
together with FR- (data not shown). In contrast, exclu- by EBO-Z luciferase virus (Figure 6A) but not by the
negative control HIV-1 JR-FL pseudotype (data notsively after pH 5 exposure, a range of 1 to 6 unambiguous
syncytia per well was consistently observed in cocul- shown). Strikingly, A7-1 was also permissive for MBG
entry, suggesting that a common factor(s) may comple-tures expressing MBG GP with FR- (Figure 5C). While
less robust than that seen with HA, this reproducible ment deficiencies of permissivity for both MBG and
EBO-Z virus entry. Correspondingly, A7-1 cells werelevel of MBG GP-induced syncytia formation facilitated
by FR- provides independent evidence that FR- inter- found by PCR amplification to carry a library insert en-
coding for full-length FR-. By Northern blot analysis,acts with MBG GP for subsequent fusion.
7 other recovered cell clones selected for EBO-Z permis-
sivity were positive for FR--specific message. More-FR- Mediates Entry by EBO-Z Virus
The genetic complementation protocol described earlier over, FR--positive F10 cells that had been selected
for MBG permissivity were infectible by both MBG andwas employed to identify factors that mediate entry by
EBO-Z virus. HeLa, but not Jurkat, are permissive for EBO-Z luciferase viruses (Figure 6B). Thus, in two inde-
Folate Receptor- Mediates Filovirus Entry
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Figure 5. Syncytia Formation in 293T Cells
by MBG GP Is Facilitated by FR-
(A) Syncytium production (100 syncytia/
well, white arrow) in 293T cells expressing
influenza hemaglutinin (HA) after pH 5 ex-
posure.
(B) No detectable syncytia in cocultures ex-
pressing MBG GP with CD4 after pH 5 ex-
posure.
(C) Syncytium production in cocultures ex-
pressing MBG GP with FR- after pH 5 expo-
sure (1 to 6 syncytia/well, black arrows).
pendent procedures designed to reconstitute permis- surface of cells expressing either MBG GP or EBO-Z
sivity for filovirus entry—one approach utilizing MBG GP (Figure 7). FR--negative CHO-K1 cells (Weitman et
pseudotypes and the other utilizing EBO-Z pseudo- al., 1992a), expressing either Ampho, MBG, or EBO-Z
types—recovered cells were found to be FR--positive GP, were incubated with bovine FBP and a polyclonal
and concurrently permissive for both MBG and EBO-Z anti-bovine FBP antibody that was nonneutralizing for
infection. These results provide genetic evidence dem- MBG or EBO-Z entry (data not shown). Samples were
onstrating that FR- mediates infection by EBO-Z as then fixed and stained with a fluorescein-conjugated
well as by MBG virus. secondary antibody in order to highlight selectively
To obtain direct genetic proof that FR- reconstitutes those cells with FBP bound to their surface. Transfected
permissivity for EBO-Z entry, Jurkat-EctR cells express- cells exposed to anti-FBP and secondary antibody in the
ing either GFP or FR-were challenged with blasti pseu- absence of FBP yielded negligible staining. Additionally,
dotypes, selected in blasticidin S, and monitored for cell cells transfected with Ampho GP exhibited only a low
viability. Comparable susceptibility to VSV-blasti entry level of background staining in the presence of FBP. In
was observed in GFP-positive and FR--positive cells contrast, cells expressing MBG GP or EBO-Z GP that
after 3 days of selection (Figure 6C). In contrast, cells were incubated with FBP displayed ring-like cell surface
expressing FR-, but not GFP, were permissive for staining. This significant and specific staining pattern
EBO-Z pseudotype entry and allowed for detectable cell indicates that MBG GP or EBO-Z GP can bind FR-.
growth after 35 days of selection. Therefore, similar to Taken together with the recovery of FR- in separate
the MBG studies, these independent genetic data dem- library transductions challenged with either MBG- or
onstrate that FR- mediates cellular entry by EBO-Z EBO-Z-blasti viruses, various FR--specific inhibition
virus. assays, the MBG GP-driven induction of cell-cell fusion
Subsequently, FR--specific inhibition strategies were by FR-, and the functional reconstitution of permissivity
pursued. HeLa cell pretreatment with phospholipase C with FR- expression constructs, we conclude that FR-
abolished entry by EBO-Z pseudotypes but did not af-  is a cell surface factor that facilitates cellular entry of
fect control virus entry (data not shown). Infection of F10 MBG and EBO-Z viruses.
cells by EBO-Z pseudotypes decreased significantly in
the presence of monoclonal anti-human FR- antibody
Discussion(Figure 6D). Furthermore, when FR--positive, monkey
Vero E6 cells, which are commonly used to propagate
In this study, a genetic strategy combining selectablefiloviruses in cell culture (Peters et al., 1996), were
pseudotype viruses packaged by filovirus GP with atreated with a polyclonal antisera raised against bovine
retroviral expression library was implemented to selectFBP, EBO-Z entry specifically decreased by nearly 60%
for reconstituted cells permissive for filovirus entry.(Figure 6E). Thus, EBO-Z entry was specifically inhibited
Pseudotype viruses have been used extensively forin the presence of separate anti-FR- antibodies in ge-
studying entry by native filoviruses (Takada et al., 1997;netically reconstituted human cells and in untransduced
Wool-Lewis and Bates, 1998; Yang et al., 1998; Chan etmonkey cells, further defining FR- as a conserved me-
al., 2000b). Furthermore, a comparison of entry require-diator of EBO-Z virus entry in different cell types and
ments of pseudotype (Figure 2A) and wild-type (Figuresmammalian species. Finally, while soluble FR- (FBP)
3B and 3C) filoviruses confirmed their dependence on theminimally affected VSV entry, it induced a substantial
same cellular pathway and validated this experimentaldose-dependent inhibition of EBO-Z infection (Figure
approach. Based on this strategy, genetically reconsti-6F). Therefore, mirroring the MBG inhibition profiles,
tuted Jurkat cells were successfully selected for permis-EBO-Z pseudotype entry was specifically abrogated by
sivity for either MBG or EBO-Z entry. In both popula-agents disrupting the interaction between virion GP
tions, surviving cells were found to be permissive forand FR-.
entry by both MBG and EBO-Z viruses. Correspondingly,
FR- cDNA inserts were recovered from both popula-FR- Binds to Cells Expressing MBG GP
tions, demonstrating genetically that FR- reconstitutesor EBO-Z GP
deficiencies for entry by both types of filoviruses.To determine if FR- binds MBG or EBO-Z GP, immuno-
fluorescence was used to detect FBP attached to the To establish directly this role in filovirus entry, several
Cell
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tity in amino acid sequence (Maziarz et al., 1999) and
differ in their size, tissue distribution (Ross et al., 1994),
or ligand binding sites (Maziarz et al., 1999). Only the
FR- isoform has been detected in normal, nonhemato-
poietic tissue other than placenta (Ross et al., 1999).
Upon binding folic acid, FR- is endocytosed in vesicles
that have been characterized as caveolae via a pathway
implicated in the uptake of other GPI-linked proteins (as
reviewed by Anderson et al., 1992). However, the exact
mechanism of endocytosis (Mayor et al., 1994) and type
of vesicle (Rijnboutt et al., 1996) used for this uptake is
controversial. After endocytosis, folic acid is released
via a decrease in intravesicular pH, followed by recycling
of FR- to the cell surface (Kamen et al., 1988; Lee et
al., 1996).
The identification of FR- as a cofactor for MBG and
EBO-Z entry is plausible in the biologic context of filovi-
ruses. The pH-dependence both of filovirus entry into
target cells (Takada et al., 1997; Wool-Lewis and Bates,
1998; Chan et al., 2000b) and of membrane fusion medi-
ated by MBG GP (Figure 5C) correlates with the pathway
of endocytosis and acidification exploited by FR- for
folic acid uptake. In addition, pretreatment of target cells
with caveolae inhibitors specifically abrogated entry by
MBG and EBO-Z pseudotype viruses, arguing that the
caveolar pathway thought to be associated with endo-
cytosis of FR- also mediates filovirus infection (C.J.E.
and M.A.G., unpublished observations). Future charac-
terization of the endocytic pathway downstream of the
initial interaction with the virion GP will be important for
understanding the filovirus life cycle and defining the
exact composition of the vesicles used by FR- and
other GPI-linked receptors for ligand uptake.
Much, but perhaps not all, of the pathology of filovirus
infection also correlates with the range of FR- expres-
sion. The fact that FR- is highly conserved in a numberFigure 6. FR- Mediates EBO-Z Virus Entry
of mammalian species (Antony, 1996) corresponds with
(A) FR--positive A7-1 cells selected for EBO-Z permissivity and (B)
the wide tropism of filoviruses in cell culture (Chan etFR--positive F10 cells selected for MBG permissivity are infectible
al., 2000b) and animal models (Geisbert and Jaax, 1998;by both MBG and EBO-Z luciferase viruses. (C) Jurkat-EctR cells
Bray et al., 1999; Connolly et al., 1999). Furthermore,expressing FR- are permissive for entry by EBO-Z-blasti virus.
Cells expressing GFP or FR- were inoculated with blasti viruses, FR- is significantly expressed in a variety of epithelial
selected in blasticidin S, and monitored for cell viability. Displayed and parenchymal cells in the lung, gonads, gastrointesti-
values are representative of two separate reconstitution procedures. nal (GI) tract, genitourinary (GU) tract (Antony, 1996),
(D) EBO-Z pseudotype entry into F10 cells is abrogated in the pres- pancreas, thyroid (Weitman et al., 1992b), and arteries
ence of anti-human FR- IgG1. (E) EBO-Z pseudotype entry into
(Weitman et al., 1992a), but not in lymphocytes (FranklinVero E6 cells is inhibited by polyclonal anti-bovine FBP. (F) Dose-
et al., 1994). Concordantly, in humans and in animaldependent decrease of EBO-Z infection of HOS cells in the presence
models, filoviruses have been documented to replicateof soluble bovine FBP. Displayed values in (A), (B), and (D)–(F) are
the means derived from three separate infections ( SEM). in parenchymal cells of the lung (Johnson et al., 1995),
gonads, GI tract, thyroid (Connolly et al., 1999), and
pancreas (Geisbert and Jaax, 1998), as well as in epithe-
experimental avenues were implemented. These in- lial cells of the GU tract (Baskerville et al., 1985; Connolly
cluded reconstitution of permissivity for filovirus entry et al., 1999), but not in lymphocytes (Geisbert et al.,
through FR- expression, inhibition of infection by blocking 2000). In addition, major targets of direct infection by
association of filovirus GP with FR-, generation of MBG filoviruses include macrophages/monocytes and fibro-
GP-triggered membrane fusion by FR-, and demon- blasts, which are present in numerous susceptible tis-
stration of purified soluble FR- specifically bound to sues, as well as hepatocytes and endothelial cells (Zaki
cells expressing either MBG or EBO-Z GP. These inde- and Goldsmith, 1999). Importantly, significant expres-
pendent genetic and biochemical studies converge sion of FR- has been documented in both macro-
upon the same conclusion that FR- acts as a significant phages (Franklin et al., 1994) and fibroblasts (Antony,
cofactor that mediates infection by MBG or EBO-Z virus. 1996). Furthermore, we found that naturally permissive
FR- is a widely expressed 38–39 kDa GPI-linked cell HOS cells, derived from fibroblast-like sarcoma cells,
surface protein that binds extracellular folic acid for cel- and Vero E6 cells, derived from fibroblast-like kidney
lular uptake (Antony, 1996). It is one of four receptor cells, both express folate receptor that is active in medi-
ating filovirus entry (Figures 4D and 6E). Although highisoforms (, , and , and ) that carry 68%–79% iden-
Folate Receptor- Mediates Filovirus Entry
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Figure 7. Soluble FR- (FBP) Binds Specifi-
cally to Cells Expressing MBG GP or EBO-Z GP
CHO-K1 cells expressing Ampho, MBG, or
EBO-Z GP were incubated with bovine FBP
and polyclonal anti-FBP (	 FBP). Control
wells were incubated in the presence of only
polyclonal anti-FBP (Phase and FBP). Cells
were then stained with a fluorescein-conju-
gated secondary antibody and analyzed by
immunofluorescence (	 FBP and  FBP).
Corresponding phase microscopy of the con-
trol wells is displayed for reference (Phase).
levels of FR- have not been reported in hepatocytes While FR- was successfully recovered as a cofactor
for filovirus entry in this approach, use of Jurkat cellsand endothelial cells, FR protein was detected in pig
hepatocytes (Villanueva et al., 1998) as well as in rat provided an imperfect cellular context to reconstitute
high levels of MBG or EBO-Z entry with either pseu-liver tissue (da Costa et al., 2000), while FR- mRNA
was detected by RT-PCR in human liver (Ross et al., dotype or wild-type (Figure 3C) viruses. T cells were
selected for this study since lymphocytes represent the1994). It is possible that these low levels of FR- are
sufficient to facilitate filovirus entry into hepatocytes or only mammalian cell type tested that consistently resists
robust infection by filoviruses in cell culture (Yang et al.,that further expression is induced in vivo (Antony, 1996).
It currently remains unclear if endothelial cells also ex- 1998; Wool-Lewis and Bates, 1998; Chan et al., 2000b)
and in animal models (Geisbert et al., 2000). However,press low yet functional receptor levels. Nonetheless,
the otherwise vast range of permissive cells with signifi- not only do Jurkat cells express little to no FR-, but
also they are typically deficient in certain endocytic pro-cant FR- expression largely matches known features
of the filovirus life cycle and strengthens our conclusion cesses such as caveolae formation (Fra et al., 1994)
proposed to be instrumental for FR--mediated folicthat FR- plays a role in propagating the spread of filovi-
rus infection in relevant cell types. acid uptake. Therefore, it is probable that Jurkat T cells
do not support robust infection because they carry mul-The fact that FR- mediates entry by either MBG or
EBO-Z virus also reinforces the hypothesis that these tiple impediments to filovirus entry. Consequently, addi-
tional cellular factors beyond FR- may be necessaryviruses exploit fundamentally similar cellular pathways
to infect cells. However, we previously described bio- to reconstitute permissivity to high levels observed in
nonmanipulated, infectible cells. Nonetheless, in combi-chemical differences in target cell entry mediated by
EBO-Z GP compared with that by MBG GP (Chan et nation with the high sensitivity of the genetic comple-
mentation protocol, the use of Jurkat T cells was suc-al., 2000b). Therefore, although both MBG and EBO-Z
viruses similarly utilize FR- for initiation of entry, it will cessful in recovering FR- for characterization as a
mediator of filovirus entry by other independent strategies.be important to determine how their entry processes
diverge. It is possible that their envelope GP may interact Delivery of cDNA libraries derived from FR--negative
permissive cells into Jurkat cells may allow for recoverydifferentially with other unknown cellular factors. In sup-
port of this hypothesis, we discovered that not all cell of other host factors that play a role independently or
in combination with FR- in the filovirus entry process.types that are naturally permissive for MBG or EBO-Z
entry express FR- (data not shown). Therefore, al- Finally, the identification of FR- as a cofactor that
mediates filovirus entry may offer a novel therapeuticthough FR- mediates MBG and EBO-Z virus entry in
certain cell types, at least one alternate factor must avenue for effectively treating the hemorrhagic fevers
caused by infection. The observation that soluble FBP,share this function in other cellular contexts. Similar
to other viruses that can interact with one of various anti-FR- antisera, and folic acid can inhibit entry by
filoviruses may provide a basis for establishing treat-receptors to enter cells such as HIV (as reviewed by
Berger et al., 1999), we hypothesize that filoviruses can ment regimens designed to block FR- from associating
with extracellular filoviruses. However, as indicated ear-utilize a family of receptors to facilitate their life cycle
in a broad range of cell types. lier, FR-may not facilitate virus entry into all cell types.
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parallel batch, Jurkat-EctR cells were transduced with pseudoviri-Nonetheless, the characterization of FR- as a cofactor
ons carrying pLIB-GFP. By quantitating GFP-positive Jurkat-EctRthat mediates filovirus entry is an important first step
cells two days after transduction, library infection was optimized toboth in gaining a molecular understanding of how filovi-
achieve a reproducible 30%–40% transduction efficiency. Se-
ruses associate with cells and in designing therapeutic lectable MBG-blasti or VSV-blasti virus was harvested and used to
measures to intervene in these key events. challenge parental cells or cells transduced with the library 48 hr
earlier, followed by transfer into medium containing blasticidin S
(ICN Pharmaceuticals, Inc., 40 
g/ml). During selection for 2–3Experimental Procedures
weeks, cells were monitored for viability by Trypan Blue exclusion.
Selected cells were expanded and subjected to limiting dilution toCell Lines
obtain monoclonal cell populations. To select for cells permissiveJurkat T cells stably expressing the ecotropic murine leukemia virus
for EBO-Z virus entry, similar procedures were performed using(MLV) receptor (Jurkat-EctR, also known as Jurkat.ecoR) were pro-
EBO-Z-blasti virus.vided by Dr. G. Nolan (Stanford University). PT67 packaging cells
were cultured as described (Clontech). Human osteosarcoma (HOS)
cells carrying a human green fluorescent protein reporter gene Challenge of Cells with Pseudotype and Wild-Type Filoviruses
driven by an HIV-2 Tat-dependent LTR were provided by Dr. D. To determine permissivity for entry by pseudotype luciferase vi-
Littman (Skirball Institute). Other cell types were cultured as recom- ruses, target cells were incubated with virus for 48–72 hr, and lucifer-
mended by the American Type Culture Collection (ATCC). ase expression was quantitated as previously described (Chan et
al., 2000b). Alternatively, Vero E6, parental, and reconstituted Jurkat-
EctR cells were inoculated with wild-type MBG virus. Immunostain-Plasmids and cDNA Library Amplification
ing was performed as previously described (Schmaljohn et al., 1995).The env-negative, HIV-1 provirus carrying a luciferase reporter gene,
pNL-Luc-ER (Connor et al., 1995), was provided by Dr. N. Landau
(Salk Institute). The env-negative, HIV-1 provirus carrying the blastic- PCR Recovery of cDNA Library Inserts from Transduced
idin S deaminase gene, pHIV-blasti, was provided by Dr. R. Sutton Jurkat-EctR Cells
(Baylor University). Expression plasmid pVSV-G encoding the vesic- Genomic DNA was extracted from Jurkat-EctR cells selected for
ular stomatitis virus-G (VSV) protein was provided by Dr. J. Burns permissivity for MBG entry using the “Easy DNA” kit (Invitrogen).
(University of California, San Diego), and pMULV-A encoding the Extracted DNA was used as a template for PCR-based amplification
amphotropic (Ampho) MLV env was provided by Dr. K. Page (Univer- using the Expand PCR kit (Roche Molecular Biochemicals) and oli-
sity of California, San Francisco). The cDNA clones encoding MBG gonucleotide primers derived from sequences flanking the library
GP and EBO-Z GP were provided by Dr. A. Sanchez (Centers for inserts. Specific DNA bands amplified in experimental samples, but
Disease Control and Prevention) and cloned into the pCMV4neo not control samples, were used for TA cloning (Invitrogen). Insert
expression vector (Chan et al., 2000b). The full-length library cDNA sequences were compared to known genomic and cDNA sequences
and truncated cDNA encoding FR- were recovered by PCR as using Entrez BLAST software.
described below. For reconstitution studies, pBabe-FR- was con- To recover cDNA inserts from cells selected for permissivity for
structed by subcloning the full-length FR- gene into the MLV ret- EBO-Z entry, RT-PCR was used for greater efficiency of library insert
roviral vector pBabeMN, provided by Dr. G. Nolan (Stanford Univer- retrieval. Total RNA was extracted from cells by the RNA STAT 60
sity), and the MLV retroviral vector encoding GFP, pMSCV2.2-IRES- method (Tel-Test, Inc.). Using total RNA as a template, RT-PCR was
GFP, was provided by Dr. W. Sha (University of California, Berkeley). performed using the First Strand cDNA Synthesis Kit for RT-PCR
The expression vector encoding the influenza hemaglutinin protein (Roche Molecular Biochemicals), followed by PCR of resulting prod-
(HA) was provided by Dr. W.F. Anderson (University of Southern ucts, TA cloning, and sequencing.
California).
DNA from the MLV retroviral HeLa cDNA library (pLIB-HeLa, 2  Reconstitution of Permissivity for MBG and EBO-Z Entry
106 independent clones) was amplified as described by Clontech. by Expression of FR-
The plasmid pLIB-GFP encoding GFP in the MLV backbone was Retroviral expression vectors encoding either FR- or GFP were
used for quantitating transduction efficiency. transduced into Jurkat-EctR cells as above for HeLa library delivery.
Equal numbers of transduced cells were inoculated (48 hr, 37C)
Antibodies with blasti viruses with polybrene (5 
g/ml) followed by transfer into
For detection of wild-type MBG virus infection, guinea pig anti-MBG medium containing blasticidin S (ICN, 40 
g/ml). During selection
antisera were used (Hevey et al., 1997). For inhibition of pseudotype for 2–5 weeks, cells were monitored for viability by Trypan Blue
virus entry, a monoclonal mouse anti-human FR- (IgG1) ascites exclusion and counted on a hemacytometer. Growth of cultures
(No. 458), provided by Dr. W. Franklin (University of Colorado Health challenged with VSV-blasti virus was quantitated after 3 days of
Sciences Center) (Franklin et al., 1994), and monoclonal mouse anti- selection. Growth of cells challenged with MBG-blasti virus or EBO-
HIV-1 p24 Gag (IgG1) ascites were compared. Similarly, polyclonal Z-blasti virus was quantitated 3 days following the initial visualiza-
antisera raised against bovine folate binding protein (FBP, Biogene- tion of viable cells in the transduced cultures. Alternatively, Jurkat-
sis) were compared with normal rabbit sera. A mouse monoclonal EctR cells were transfected with the relevant expression vectors
anti-soluble bovine FR- (IgG1 clone 42/033, Biogenesis) or IgG1 and challenged with luciferase viruses as described above.
isotype control was used for flow cytometry of human cells. To
detect simian FR- on Vero E6 cells more efficiently, the mouse Inhibition of Pseudotype Virus Entry by FR--Specific Blockers
anti-human FR- (IgG1) was used. To detect cell surface binding of HeLa cells or reconstituted Jurkat-EctR F10 cells were treated with
FBP, goat anti-bovine FBP (Rockland) and fluorescein-conjugated phospholipase C (ICN) for 2 hr at 37C, washed, and challenged
rabbit anti-goat IgG F(c) (Rockland) were used. with luciferase viruses for 4 hr at 37C. Luciferase expression was
assessed after 72 hr. F10 cells were preincubated with anti-human
FR- (IgG1) or anti-HIV p24 Gag (IgG1) for 15 min at 4C. Cells werePseudotype Virus Preparation and Genetic Reconstitution
of Permissivity for Filovirus Entry challenged with luciferase virus in the presence of antisera, followed
by assessment of luciferase expression. Vero E6 cells were preincu-To prepare HIV-1 pseudotype virus packaged by viral GP, an HIV-1
proviral construct was cotransfected with a GP expression vector bated with medium containing polyclonal anti-FBP (with 0.1% so-
dium azide) or normal rabbit sera (with 0.1% sodium azide) for 15in 293T cells as previously described (Chan et al., 2000b). To recon-
stitute permissivity for MBG entry, library DNA (3 
g/well of 6-well min at 4C, followed by virus challenge as above. HOS cells were
preincubated at 4C for 30 min with media (pH 8.3) containing folicplate) or pLIB-GFP (3 
g/well) was packaged into pseudovirions by
transfecting PT67 cells and harvesting culture supernatants. Jurkat- acid (ICN) added from a 220 mM stock (1 M NaOH). Cells were
challenged with luciferase viruses in the presence of folic acid. AfterEctR cells (8.0  107) were then divided into 10 separate batches
and transduced with library-containing viral supernatants with poly- 12 hr, culture medium was replaced, and luciferase expression was
assessed after 48 hr. Finally, pseudotype virus produced in thebrene (5 
g/ml) via spin infection (2.5  103 RPM, 32C, 2 hr). In a
Folate Receptor- Mediates Filovirus Entry
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absence of serum or folic acid was preincubated with soluble FR- duction of cellular detachment by envelope glycoproteins of Mar-
burg and Ebola (Zaire) viruses. J. Gen. Virol. 81, 2155–2159.(FBP; Svendsen et al., 1982) derived from bovine milk (Sigma) for
15 min at 4C. HOS cells were challenged with virus supernatants Chan, S.Y., Speck, R.F., Ma, M.C., and Goldsmith, M.A. (2000b).
alone or with virus mixtures containing FBP for 4 hr at 37C. Cells Distinct mechanisms of entry by envelope glycoproteins of Marburg
were then washed, medium was replaced, and luciferase expression and Ebola (Zaire) viruses. J. Virol. 74, 4933–4937.
was assessed after 72 hr.
Connolly, B.M., Steele, K.E., Davis, K.J., Geisbert, T.W., Kell, W.M.,
Jaax, N.K., and Jahrling, P.B. (1999). Pathogenesis of experimentalQuantitation of Cell-Cell Fusion Generated by MBG GP
Ebola virus infection in guinea pigs. J. Infect. Dis. 179 (Suppl 1),293T cells were transfected with envelope GP (MBG GP or HA) or
S203–S217.receptor expression vector (CD4 or FR-) as previously described
Connor, R.I., Chen, B.K., Choe, S., and Landau, N.R. (1995). Vpr is(Chan et al., 2000b). After 24 hr, cells were detached using enzyme-
required for efficient replication of human immunodeficiency virusfree Cell Dissociation Buffer (Life Technologies). The appropriately
type-1 in mononuclear phagocytes. Virology 206, 935–944.transfected cells were mixed (1:1 ratio), cultured on poly-L-lysine-
coated (Sigma) 24-well plates as previously described (Allan, 2000), da Costa, M., Rothenberg, S.P., Sadasivan, E., Regec, A., and Qian,
and incubated at 37C for 48 hr. To trigger syncytia (3 nuclei), cells L. (2000). Folate deficiency reduces the GPI-anchored folate-binding
were incubated in either 75 mM MES/10 mM HEPES buffer (pH 5) protein in rat renal tubules. Am. J. Physiol. Cell Physiol. 278, C812–
or 10 mM HEPES buffer (pH 7) for 10 min at 37C as previously C821.
described (Vey et al., 1992). The buffer was then replaced with Fra, A.M., Williamson, E., Simons, K., and Parton, R.G. (1994). Deter-
medium. Syncytia were scored after 24 hr. gent-insoluble glycolipid microdomains in lymphocytes in the ab-
sence of caveolae. J. Biol. Chem. 269, 30745–30748.
Binding of Cells Expressing MBG GP or EBO-Z GP with FBP
Franklin, W.A., Waintrub, M., Edwards, D., Christensen, K., Prende-CHO-K1 cells were plated in chamber slides coated with poly-L-
grast, P., Woods, J., Bunn, P.A., and Kolhouse, J.F. (1994). New anti-lysine and transfected with MBG GP, EBO-Z GP, or Ampho GP
lung-cancer antibody cluster 12 reacts with human folate receptorsexpression vectors using LipofectAMINE (Life Technologies, Inc.).
present on adenocarcinoma. Int. J. Cancer Suppl. 8, 89–95.After 48 hr, bovine FBP (33 
g/ml) was incubated in the presence
of nonneutralizing polyclonal goat anti-bovine FBP (250 
g/ml) for Geisbert, T.W., and Jaax, N.K. (1998). Marburg hemorrhagic fever:
15 min at 4C in RPMI 1640 devoid of folic acid. Cells were then report of a case studied by immunohistochemistry and electron
incubated in the presence of the FBP/anti-FBP mixture or in the microscopy. Ultrastruct. Pathol. 22, 3–17.
presence of anti-FBP alone for 30 min at 4C. Cells were washed Geisbert, T.W., Hensley, L.E., Gibb, T.R., Steele, K.E., Jaax, N.K.,
(3  ice cold PBS), fixed in 2% paraformaldehyde, washed, and and Jahrling, P.B. (2000). Apoptosis induced in vitro and in vivo
incubated with fluorescein-conjugated secondary antibody (4 
g/ during infection by Ebola and Marburg viruses. Lab. Invest. 80,
ml) for 45 min at 25C in the dark. Slides were washed, mounted, 171–186.
and analyzed by fluorescence microscopy.
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